Interleukin-1 superfamily member, interleukin-33, in periodontal diseases

Biotechnic and Histochemistry

Volumn 89, Issue 3, 2014, Pages 209-214

  Beklen, A ^a,b   Memet, G Tsaous ^c  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

^b BOGAZICI UNIVERSITY   (Turkey)

^c Tepebasi Oral and Dental Health Hospital   (Turkey)

Author keywords

Fibroblasts; IL 33; Periodontitis; Tumor necrosis factor

Indexed keywords

IL33 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; CYTOLOGY; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; GINGIVA; HUMAN; INFLAMMATION; MACROPHAGE; METABOLISM; PERIODONTAL DISEASE;

ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; GINGIVA; HUMANS; INFLAMMATION; INTERLEUKINS; MACROPHAGES; PERIODONTAL DISEASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84896481497     PISSN: 10520295     EISSN: 14737760     Source Type: Journal    
DOI: 10.3109/10520295.2013.832800     Document Type: Article

References (28)

1. Baekkevold ES, Roussigné M, Yamanaka T, Johansen FE, Jahnsen FL, Amalric F, Brandtzaeg P, Erard M, Haraldsen G, Girard JP (2003) Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am. J. Pathol. 163: 69-79.
2. Berglundh T, Donati M (2005) Aspects of adaptive host response in periodontitis. J. Clin. Periodontol. 32: 87-107.
3. Buduneli N, Özçaka Ö, Nalbantsoy A (2012) Inter-leukin-33 levels in gingival crevicular fluid, saliva, or plasma do not differentiate chronic periodontitis. J. Peri-odontol. 83: 362-368.
4. Carriere V, Roussel L, Ortega N, Lacorre DA, Americh L, Aguilar L, Bouche G, Girard JP (2007) IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chro-matin-associated nuclear factor in vivo. Proc. Natl. Acad. Sci. USA 104: 282-287.
5. Cayrol C, Girard JP (2009) The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc. Natl. Acad. Sci. USA 106: 9021-9026.
6. Dinarello CA (2011) Interleukin-1 in the pathogen-esis and treatment of inf ammatory diseases. Blood 117: 3720-3732.
7. Giannobile WV (2008) Host-response therapeutics for periodontal diseases. J. Periodontol. 79: 1592-1600.
8. Jones LA, Roberts F, Nickdel MB, Brombacher F, McKenzie AN, Henriquez FL, Alexander J, Roberts CW (2010) IL-33 receptor (T1/ST2) signalling is necessary to prevent the development of encephalitis in mice infected with Toxoplasma gondii. Eur. J. Immunol. 40: 426-436.
9. Kakkar R, Lee RT (2008) The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat. Rev. Drug Discov. 7: 827-840.
10. Kobori A, Yagi Y, Imaeda H, Ban H, Bamba S, Tsujikawa T, Saito Y, Fujiyama Y, Andoh A (2010) Interleukin-33 expression is specif cally enhanced in inf amed mucosa of ulcerative colitis. J. Gastroenterol. 45: 999-1007.
11. Kunisch E, Chakilam S, Gandesiri M, Kinne RW (2012) IL-33 regulates TNF-α dependent effects in synovial fbroblasts. Int. J. Mol. Med. 29: 530-540.
12. Lee HC, Ziegler SF (2007) Inducible expression of the proallergic cytokine thymic stromal lymphopoietin in airway epithelial cells is controlled by NFkappaB. Proc. Natl. Acad. Sci. USA 104: 914-919.
13. Lopetuso LR, Scaldaferri F, Pizarro TT (2012) Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fbrosis. Fibrogen Tissue Rep. 5: 18.
14. Martinon F, Tschopp J (2004) Inf ammatory caspases: linking an intracellular innate immune system to autoin-f ammatory diseases. Cell 117: 561-574.
15. Masada MP, Persson R, Kenney JS, Lee SW, Page RC, Allison AC (1990) Measurement of interleukin-1 α and-1 β in gingival crevicular fluid: implications for the pathogenesis of periodontal disease. J. Periodont. Res. 25: 156-163.
16. Matsuyama Y, Okazaki H, Tamemoto H, Kimura H, Kamata Y, Nagatani K, Nagashima T, Hayakawa M, Iwamoto M, Yoshio T, Tominaga S, Minota S (2010) Increased levels of interleukin 33 in sera and synovial fluid from patients with active rheumatoid arthritis. J. Rheumatol. 37: 18-25.
17. May LT, Ndubuisi MI, Patel K, García D (1995) Inter-leukin-6 chaperones in blood. Ann. NY Acad. Sci. 762: 120-128.
18. Moro K, Yamada T, Tanabe M, Takeuchi T, Ikawa T, Kawamoto H, Furusawa J, Ohtani M, Fujii H, Koyasu S (2010) Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 463: 540-544.
19. Moussion C, Ortega N, Girard JP (2008) The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? PLoS One 3: e3331.
20. Nomura K, Kojima T, Fuchimoto J, Obata K, Keira T, Himi T, Himi T, Sawada N (2012) Regulation of inter-leukin-33 and thymic stromal lymphopoietin in human nasal f broblasts by proinf ammatory cytokines. Laryngoscope 122: 1185-1192.
21. Ohno T, Oboki K, Kajiwara N, Morii E, Aozasa K, Flavell RA, Saito H, Nakae S (2009) Caspase-1, caspase-8, and calpain are dispensable for IL-33 release by macrophages. J. Immunol. 183: 7890-7897.
22. Palmer G, Talabot-Ayer D, Lamacchia C, Toy D, Seemayer CA, Viatte S, Finckh A, Smith DE, Gabay C (2009) Inhibition of interleukin-33 signalling attenuates the severity of experimental arthritis. Arthr. Rheum. 60: 738-749.
23. Sanada S, Hakuno D, Higgins LJ, Schreiter ER, McKenzie AN, Lee RT (2007) IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signalling system. J. Clin. Invest. 117: 1538-1549.
24. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, Moshref M, Qin J, Li X, Gorman DM, Bazan JF, Kastelein RA (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23: 479-490.
25. Takada H, Mihara J, Morisaki I, Hamada S (1991) Induction of interleukin-1 and-6 in human gingival f broblast cultures stimulated with Bacteroides lipopolysaccharides. Infect. Immun. 59: 295-301.
26. Wagenaar JF, Gasem MH, Goris MG, Leefang M, Harts-keerl RA, van der Poll T, van Veer C, van Gorp EC (2009) Soluble ST2 levels are associated with bleeding in patients with severe Leptospirosis. PLoS Negl. Trop. Dis. 3: e453.
27. Wood IS, Wang B, Trayhurn P (2009) IL-33, a recently identif ed interleukin-1 gene family member, is expressed in human adipocytes. Biochem. Biophys. Res. Commun. 384: 105-109.
28. Xu D, Jiang HR, Kewin P, Li Y, Mu R, Fraser AR, Pitman N, Kurowska-Stolarska M, McKenzie AN, McInnes IB, Liew FY (2008). IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc. Natl. Acad. Sci. USA 105: 10913-10918.